Literature DB >> 6325123

Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells.

R G Rosenfeld, G Ceda, D M Wilson, L A Dollar, A R Hoffman.   

Abstract

Primary cultures of rat anterior pituitary cells were assessed for the presence of specific receptors for insulin and for the somatomedin peptides, insulin-like growth factors I and II (IGF-I and IGF-II). Specific binding per 100,000 pituitary cells averaged 9.45 +/- 1.69% (mean +/- SD) for [125I]IGF-II, 0.83 +/- 0.06% for [125I]IGF-I, and only 0.11% for [125I]insulin, IGF-II was twice as potent as IGF-I in displacing [125I]IGF-II, while insulin was totally nonreactive, IGF-I was 5-fold more potent than IGF-II at displacing [125I]IGF-I and 1000-fold more potent than insulin. Scatchard analysis of [125I]IGF-II binding revealed a curvilinear plot, which could be resolved into a high affinity receptor with a Ka of 7.0 X 10(8) M-1 and 120,000 receptor sites/cell, and a low affinity receptor with a Ka of 1.1 X 10(8) M-1 and 720,000 receptor sites/cell. The existence of abundant high affinity somatomedin receptors (especially for IGF-II) on rat anterior pituitary cells is consistent with a potential role for these peptides in the regulation of GH secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325123     DOI: 10.1210/endo-114-5-1571

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

Review 2.  IGFs in the feedback control of GH secretion: Hypothalamic and/or pituitary action?

Authors:  G P Ceda
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

3.  Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats.

Authors:  M C Ghigo; A Torsello; R Grilli; M Luoni; M Guidi; S G Cella; V Locatelli; E E Müller
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

Review 4.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

5.  Insulin-like growth factor-1 causes a switch-like reduction of endogenous growth hormone mRNA in rat MtT/S somatotroph cells.

Authors:  T C Voss; T M Mangin; D L Hurley
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

Review 6.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 7.  Insulin and insulin-like growth factor receptors in the nervous system.

Authors:  M Adamo; M K Raizada; D LeRoith
Journal:  Mol Neurobiol       Date:  1989 Spring-Summer       Impact factor: 5.590

8.  Receptor autoradiographic analysis of insulin-like growth factor-I (IGF-I) binding sites in rat forebrain and pituitary gland.

Authors:  K Matsuo; M Niwa; M Kurihara; K Shigematsu; S Yamashita; M Ozaki; S Nagataki
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

9.  Insulin regulation of rat growth hormone gene transcription.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

10.  Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.